From: Association of cetuximab with adverse pulmonary events in cancer patients: a comprehensive review
Number | Ref: | Author | Year | Study Type | Cancer Type | Combined Agents | Pulmonary Reactions |
---|---|---|---|---|---|---|---|
1 | 51 | Vermorken | 2008 | Phase II | SCCHN | platinum | dyspnea, Pneumonia |
2 | 29 | Koo | 2007 | Phase II | Colorectal | FOLFIRI, irinotecan | dyspnea |
3 | 8 | Leard | 2007 | case | SCCHN | Â | DAD |
4 | 16 | Burtness | 2005 | Phase III | SCCHN | cisplatin | dyspnea, hypoxia |
5 | 15 | Bourhis | 2006 | Phase I/II | SCCHN | cisplatin, carboplatin/5-fluorouracil | respiratory symptoms |
6 | 12 | Baselga | 2005 | Phase II | SCCHN | platinum | respiratory disorder |
7 | 50 | Vermorken | 2007 | review | SCCHN | cisplatinum, carboplatin | dyspnea, infusion rxn |
8 | 20 | Cunningham | 2004 | Prospective | Colorectal | irinotecan | dyspnea |
9 | 53 | Xiong | 2004 | Phase II | Pancreatic | gemcitabine | Pneumonia, Sepsis, PE, Pulm Insufficeincy |
10 | 19 | Chan | 2005 | Phase II | Nasopharyngeal | carboplatin | Pleural Effusion, Dyspnea, Pneumonia |
11 | 40 | Robert | 2005 | Phase I/II | NSCLC | gemcitibine, carboplatin | Pulmonary Embolism |
12 | 23 | Hanna | 2006 | Phase II | NSCLC | Â | Dyspnea |
13 | 54 | Zhu | 2007 | Phase II | HCC | Â | Cough |
14 | 31 | Machiels | 2007 | Phase I/II | Colorectal | capecitabine, ExBR | Pulmonary Embolism, Pulm Infetion |
15 | 13 | Bonner | 2006 | RCT | SCCHN | ExBR | cough, increased sputum |
16 | 32 | Martin-Martorell | 2008 | Phase II | Colorectal | irinotecan | none |
17 | 28 | Konner | 2008 | Phase II | Ovarian | carboplatin, paclitaxel | Dyspnea |
18 | 56 | Hughes | 2008 | Phase I/II | NSCLC | platinum, ExBR 64 Gy | dyspnea, pneumonitis, pulm embolism, pneumonia |
19 | 11 | Asnacios | 2008 | Phase II | HCC | oxaliplatin, gemcitabine | none |
20 | 18 | Cascinu | 2008 | Phase II | Pancreatic | cisplatin, gemcitabine | none |
21 | 35 | Paule | 2007 | Phase II | Cholangiocarcinoma | oxaliplatin, gemcitabine | none |
22 | 47 | Tabernero | 2007 | Phase II | Colorectal | oxaliplatin, 5-fluorouracil | Dyspnea |
23 | 27 | Jonker | 2007 | rescue | Colorectal | prev-oxal, irinotecan, flouropyrimidine | dyspnea |
24 | 42 | Safran | 2008 | phase II | Espohageal | carboplatin, paclitaxel, ExBR | Pneumonia |
25 | 26 | Ibrahim | 2007 | phase II | Colorectal | oxaliplatin, irinotecan | none |
26 | 38 | Pinto | 2007 | phase II | Gastric/GE | irinotecan, 5-fluorouracil | none |
27 | 46 | Souglakos | 2007 | phase II | Colorectal | oxaliplatin, capecitabine | none |
28 | 30 | Lenz | 2006 | phase II | Colorectal | prev-oxaloplatin, irinotecan, flouropyrimidine | none |
29 | 25 | Hofheinz | 2006 | phase I | Colorectal | capecitabine, irinotecan, ExBR | none |
30 | 24 | Herbst | 2005 | phase II | SCCHN | cisplatin | none |
31 | 43 | Saltz | 2004 | phase II | Colorectal | previous irinotecan | none |
32 | 52 | Vincenzi | 2006 | phase II | Colorectal | irinotecan | none |
33 | 37 | Pfister | 2006 | phase II | SCCHN | cisplatin, ExBR | pneumonia |
34 | 39 | Robert | 2001 | phase I | SCCHN | ExBR | none |
35 | 48 | Thienelt | 2005 | Phase I/II | NSCLC | carboplatin, paclitaxel | pulmonary embolism |
36 | 34 | Neyns | 2008 | Phase II | Colorectal | oxaloplatin or irinotecan | Interstitial pneumonitis |
37 | 10 | Arnold | 2008 | Phase Ib/II | Colorectal | oxaliplatin, 5-fluorouracil | None |
38 | 45 | Sobrero | 2008 | Phase III | Colorectal | irinotecan | None |
39 | 44 | Secord | 2008 | Phase II | Ovarian | carboplatin | Pulmonary rxn |
40 | 14 | Borner | 2008 | Phase II | Colorectal | oxaliplatin, capecitabine | none |
41 | 21 | Gamucci | 2008 | Phase II | Colorectal | irinotecan | none |
42 | 49 | Tol | 2008 | Phase III | Colorectal | capecitabine, Oxaliplatin + Bevacizumab | Pulmonary embolism, Respiratory Insuffiency |
43 | 17 | Butts | 2007 | Phase II | NSCLC | gemcitabine, Cisplatin, Carboplatin | dyspnea, Cough, Pneumonia |
44 | 36 | Pessino | 2008 | Phase II | Colorectal | none | none |
45 | 5 | Rosell | 2008 | Phase II | NSCLC | cisplatin, vinorelbine | resp symptoms |
46 | 41 | Rodel | 2008 | Phase I/II | Colorectal | capecitabine, ExBR, Oxaliplatin | none |
47 | 33 | Modi | 2006 | Phase I | Breast | paclitaxel | none |
48 | 22 | Gebbia | 2006 | retrospect rev | Colorectal | irinotecan | none |
49 | 58 | Pirker | 2009 | Phase III | NSCLC | cisplatin, vinorelbine | dyspnea, respiratory failure, pulmonary embolism |
50 | 57 | Belani | 2008 | Phase II | NSCLC | carboplatin, docetaxel | none |
51 | 55 | Gridelli | 2009 | Phase II | NSCLC | gemcitibine | pulmonary symptoms |
52 | 59 | Shin | 2001 | Phase I | SSCHN | Cisplatin | Shortness of Breath |
53 | 60 | Baselga | 2000 | Phase I | SSCHN/NSCLC | Cisplatin | Dyspnea |